• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

前药方法：提高药物溶解度的成功工具。

The Prodrug Approach: A Successful Tool for Improving Drug Solubility.

作者信息

Jornada Daniela Hartmann, dos Santos Fernandes Guilherme Felipe, Chiba Diego Eidy, de Melo Thais Regina Ferreira, dos Santos Jean Leandro, Chung Man Chin

机构信息

Faculdade de Ciências Farmacêuticas, UNESP-University Estadual Paulista, Rodovia Araraquara Jaú Km 01, 14801-902 Araraquara, São Paulo, Brasil.

出版信息

Molecules. 2015 Dec 29;21(1):42. doi: 10.3390/molecules21010042.

DOI:10.3390/molecules21010042
PMID:26729077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6273601/
Abstract

Prodrug design is a widely known molecular modification strategy that aims to optimize the physicochemical and pharmacological properties of drugs to improve their solubility and pharmacokinetic features and decrease their toxicity. A lack of solubility is one of the main obstacles to drug development. This review aims to describe recent advances in the improvement of solubility via the prodrug approach. The main chemical carriers and examples of successful strategies will be discussed, highlighting the advances of this field in the last ten years.

摘要

前药设计是一种广为人知的分子修饰策略，旨在优化药物的物理化学和药理性质，以提高其溶解度和药代动力学特征，并降低其毒性。溶解度不足是药物开发的主要障碍之一。本综述旨在描述通过前药方法改善溶解度的最新进展。将讨论主要的化学载体和成功策略的实例，突出该领域在过去十年中的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/6c74e0dde872/molecules-21-00042-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/6568bfcd3c0f/molecules-21-00042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/d4c45a053438/molecules-21-00042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/d92f2bf822a7/molecules-21-00042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/19ce99304dc9/molecules-21-00042-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/d19ee12d4868/molecules-21-00042-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/922ab3e7c77f/molecules-21-00042-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/3bdb314b1f26/molecules-21-00042-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/a1647032fff4/molecules-21-00042-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/d40a10145221/molecules-21-00042-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/6d8f415888a5/molecules-21-00042-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/0d341ee45f76/molecules-21-00042-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/143a9f62472e/molecules-21-00042-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/36c7bac5afee/molecules-21-00042-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/f72f53bbc036/molecules-21-00042-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/4d8418532b57/molecules-21-00042-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/493d4b89746f/molecules-21-00042-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/ff5d8b937d7d/molecules-21-00042-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/769e273928fc/molecules-21-00042-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/9bdf74401ff4/molecules-21-00042-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/52490f31bcc6/molecules-21-00042-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/d02e42c0e3a4/molecules-21-00042-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/14c938e524b6/molecules-21-00042-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/86423912b367/molecules-21-00042-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/3704855551a8/molecules-21-00042-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/26aae8f5a644/molecules-21-00042-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/5a9f9f53dbe2/molecules-21-00042-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/0375475fe679/molecules-21-00042-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/0a8e632de46c/molecules-21-00042-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/b7e4aa08e14c/molecules-21-00042-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/1cc11d28ca8f/molecules-21-00042-g030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/85bad07f9da0/molecules-21-00042-g031.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/6c74e0dde872/molecules-21-00042-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/6568bfcd3c0f/molecules-21-00042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/d4c45a053438/molecules-21-00042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/d92f2bf822a7/molecules-21-00042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/19ce99304dc9/molecules-21-00042-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/d19ee12d4868/molecules-21-00042-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/922ab3e7c77f/molecules-21-00042-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/3bdb314b1f26/molecules-21-00042-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/a1647032fff4/molecules-21-00042-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/d40a10145221/molecules-21-00042-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/6d8f415888a5/molecules-21-00042-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/0d341ee45f76/molecules-21-00042-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/143a9f62472e/molecules-21-00042-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/36c7bac5afee/molecules-21-00042-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/f72f53bbc036/molecules-21-00042-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/4d8418532b57/molecules-21-00042-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/493d4b89746f/molecules-21-00042-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/ff5d8b937d7d/molecules-21-00042-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/769e273928fc/molecules-21-00042-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/9bdf74401ff4/molecules-21-00042-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/52490f31bcc6/molecules-21-00042-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/d02e42c0e3a4/molecules-21-00042-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/14c938e524b6/molecules-21-00042-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/86423912b367/molecules-21-00042-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/3704855551a8/molecules-21-00042-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/26aae8f5a644/molecules-21-00042-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/5a9f9f53dbe2/molecules-21-00042-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/0375475fe679/molecules-21-00042-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/0a8e632de46c/molecules-21-00042-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/b7e4aa08e14c/molecules-21-00042-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/1cc11d28ca8f/molecules-21-00042-g030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/85bad07f9da0/molecules-21-00042-g031.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e376/6273601/6c74e0dde872/molecules-21-00042-g032.jpg

相似文献

1
The Prodrug Approach: A Successful Tool for Improving Drug Solubility.前药方法：提高药物溶解度的成功工具。
Molecules. 2015 Dec 29;21(1):42. doi: 10.3390/molecules21010042.
2
Is prodrug design an approach to increase water solubility?前药设计是否是一种提高水溶性的方法？
Int J Pharm. 2019 Sep 10;568:118498. doi: 10.1016/j.ijpharm.2019.118498. Epub 2019 Jul 10.
3
Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.HIV-1蛋白酶抑制剂KNI-727的水溶性前药的开发：基于自发化学裂解的前药更高胃肠道吸收的转化时间的重要性。
J Med Chem. 2003 Sep 11;46(19):4124-35. doi: 10.1021/jm030009m.
4
Current prodrug design for drug discovery.药物研发中的当前前药设计。
Curr Pharm Des. 2009;15(19):2236-50. doi: 10.2174/138161209788682523.
5
Prodrugs - an efficient way to breach delivery and targeting barriers.前药-突破递药和靶向障碍的有效途径。
Curr Top Med Chem. 2011;11(18):2265-87. doi: 10.2174/156802611797183230.
6
Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.前药设计改善药代动力学和药物传递特性：对发现科学家的挑战。
Curr Med Chem. 2010;17(32):3874-908. doi: 10.2174/092986710793205426.
7
Prodrugs: design and clinical applications.前体药物：设计与临床应用
Nat Rev Drug Discov. 2008 Mar;7(3):255-70. doi: 10.1038/nrd2468.
8
Prodrug strategies to overcome poor water solubility.克服水溶性差的前药策略。
Adv Drug Deliv Rev. 2007 Jul 30;59(7):677-94. doi: 10.1016/j.addr.2007.05.013. Epub 2007 May 29.
9
Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption.无定形固体分散体或前药：增加药物吸收的互补策略。
J Pharm Sci. 2016 Sep;105(9):2498-2508. doi: 10.1016/j.xphs.2015.11.004. Epub 2016 Jan 22.
10
Structure modification: a successful tool for prodrug design.结构修饰：前药设计的一种成功工具。
Future Med Chem. 2023 Feb;15(4):379-393. doi: 10.4155/fmc-2022-0309. Epub 2023 Mar 22.

引用本文的文献

1
Targeting iron regulatory protein 2 (IRP2) to disrupt iron metabolism enhances radiosensitivity through mitochondrial dysfunction in breast cancer cells.靶向铁调节蛋白2（IRP2）以破坏铁代谢，通过乳腺癌细胞中的线粒体功能障碍增强放射敏感性。
Cell Death Discov. 2025 Jul 31;11(1):357. doi: 10.1038/s41420-025-02653-z.
2
Pharmacological potential of natural chalcones: a recent studies and future perspective.天然查尔酮的药理潜力：近期研究与未来展望
Front Pharmacol. 2025 Jun 17;16:1570385. doi: 10.3389/fphar.2025.1570385. eCollection 2025.
3
Selective Phosphorylation of Phenols and Benzenediols by the Kinase PsiK and Variants Thereof.

本文引用的文献

1
NSAIDs do not require the presence of a carboxylic acid to exert their anti-inflammatory effect - why do we keep using it?非甾体抗炎药发挥抗炎作用并不需要羧酸的存在——那我们为何还一直使用它呢？
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1018-28. doi: 10.3109/14756366.2015.1088840. Epub 2015 Sep 24.
2
Drug Carrier for Photodynamic Cancer Therapy.用于光动力癌症治疗的药物载体
Int J Mol Sci. 2015 Sep 14;16(9):22094-136. doi: 10.3390/ijms160922094.
3
Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury.
激酶PsiK及其变体对酚类和苯二酚的选择性磷酸化作用
Angew Chem Int Ed Engl. 2025 Jun 17:e202503538. doi: 10.1002/anie.202503538.
4
Pharmacophore-based virtual screening and investigations of small molecule library for discovery of human hepatic ketohexokinase inhibitors for the treatment of fructose metabolic disorders.基于药效团的虚拟筛选及小分子文库研究，以发现用于治疗果糖代谢紊乱的人肝脏酮己糖激酶抑制剂。
Front Pharmacol. 2025 Apr 7;16:1531512. doi: 10.3389/fphar.2025.1531512. eCollection 2025.
5
Formulation Strategy of BCS-II Drugs by Coupling Mechanistic In-Vitro and Nonclinical In-Vivo Data with PBPK: Fundamentals of Absorption-Dissolution to Parameterization of Modelling and Simulation.通过将体外机制性数据和非临床体内数据与生理药代动力学（PBPK）相结合来制定BCS-II类药物的策略：从吸收-溶出基础到建模与模拟的参数化
AAPS PharmSciTech. 2025 Apr 17;26(5):106. doi: 10.1208/s12249-025-03093-9.
6
Prodrug Approach as a Strategy to Enhance Drug Permeability.前药策略作为增强药物渗透性的一种方法。
Pharmaceuticals (Basel). 2025 Feb 21;18(3):297. doi: 10.3390/ph18030297.
7
Current Trends in Clinical Trials of Prodrugs.前体药物临床试验的当前趋势。
Pharmaceuticals (Basel). 2025 Feb 4;18(2):210. doi: 10.3390/ph18020210.
8
Design, synthesis and biological evaluation of novel dualaction statin conjugates with triglyceride and cholesterol lowering activities.具有降低甘油三酯和胆固醇活性的新型双作用他汀类共轭物的设计、合成及生物学评价
Mol Divers. 2025 Feb 23. doi: 10.1007/s11030-025-11134-5.
9
Synthesis and Biological Evaluation of 20(S)-Substituted FL118 Conjugates as Novel Antitumor Agents.新型抗肿瘤药物20(S)-取代FL118缀合物的合成与生物学评价
J Mol Struct. 2022 Nov 15;1268. doi: 10.1016/j.molstruc.2022.133661. Epub 2022 Jul 7.
10
Exploring the 3,5-Dibromo-4,6-dimethoxychalcones and Their Flavone Derivatives as Dual α-Glucosidase and α-Amylase Inhibitors with Antioxidant and Anticancer Potential.探索3,5-二溴-4,6-二甲氧基查尔酮及其黄酮衍生物作为具有抗氧化和抗癌潜力的双α-葡萄糖苷酶和α-淀粉酶抑制剂。
Antioxidants (Basel). 2024 Oct 17;13(10):1255. doi: 10.3390/antiox13101255.
水溶性基质金属蛋白酶-9抑制剂可减少重度创伤性脑损伤后的损伤体积。
ACS Chem Neurosci. 2015 Oct 21;6(10):1658-64. doi: 10.1021/acschemneuro.5b00140. Epub 2015 Aug 14.
4
Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IV.细菌DNA回旋酶和拓扑异构酶IV双重抑制剂的水溶性前药的发现与表征
ACS Med Chem Lett. 2015 Jun 22;6(7):822-6. doi: 10.1021/acsmedchemlett.5b00196. eCollection 2015 Jul 9.
5
A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures.醋酸艾司利卡西平治疗部分性发作的疗效与安全性综述。
Ther Adv Neurol Disord. 2015 Jul;8(4):178-86. doi: 10.1177/1756285615589711.
6
Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.藤黄酸通过线粒体途径诱导细胞凋亡并抑制结直肠癌肿瘤生长。
World J Gastroenterol. 2015 May 28;21(20):6194-205. doi: 10.3748/wjg.v21.i20.6194.
7
Tedizolid Phosphate: a Next-Generation Oxazolidinone.磷酸泰地唑胺：新一代恶唑烷酮类药物。
Infect Dis Ther. 2015 Feb 24;4(1):1-14. doi: 10.1007/s40121-015-0060-3.
8
Water-soluble prodrugs of paclitaxel containing self-immolative disulfide linkers.含有自毁型二硫键连接子的紫杉醇水溶性前药。
Bioorg Med Chem Lett. 2015 Jan 1;25(1):122-7. doi: 10.1016/j.bmcl.2014.10.088. Epub 2014 Nov 12.
9
A highly water soluble benzimidazole derivative useful for the treatment of fasciolosis.一种用于治疗片形吸虫病的高度水溶性苯并咪唑衍生物。
Bioorg Med Chem Lett. 2014 Dec 15;24(24):5814-5817. doi: 10.1016/j.bmcl.2014.10.017. Epub 2014 Oct 13.
10
Prodrugs of phosphonates and phosphates: crossing the membrane barrier.膦酸盐和磷酸盐的前药：跨越膜屏障
Top Curr Chem. 2015;360:115-60. doi: 10.1007/128_2014_561.